Literature DB >> 31764946

Implementation Strategies for Cardiovascular Polypills.

Mark D Huffman1,2, Abdul Salam3, Anushka Patel2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31764946     DOI: 10.1001/jama.2019.18102

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Implementation of fixed-dose combination therapy for secondary prevention of atherosclerotic cardiovascular disease among Syrian refugees in Lebanon: a qualitative evaluation.

Authors:  Pablo Perel; Philippa Boulle; Adrianna Murphy; Ruth Willis; Éimhín Ansbro; Sahar Masri; Nour Kabbara; Tonia Dabbousy; Sola Bahous; Lucas Molfino
Journal:  BMC Health Serv Res       Date:  2022-06-04       Impact factor: 2.908

2.  Exercise versus fixed-dose combination therapy for cardiovascular risk factors control and atherosclerotic disease prevention: a network meta-analysis protocol.

Authors:  Diana P Pozuelo-Carrascosa; Iván Cavero-Redondo; Ruben Fernández Rodríguez; Carlos Pascual Morena; Irene Sequí-Domínguez; Vicente Martinez-Vizcaino
Journal:  BMJ Open       Date:  2020-07-08       Impact factor: 2.692

3.  Effect of a Combination of Citrus Flavones and Flavanones and Olive Polyphenols for the Reduction of Cardiovascular Disease Risk: An Exploratory Randomized, Double-Blind, Placebo-Controlled Study in Healthy Subjects.

Authors:  Maravillas Sánchez Macarro; Juan Pablo Martínez Rodríguez; Enrique Bernal Morell; Silvia Pérez-Piñero; Desirée Victoria-Montesinos; Ana María García-Muñoz; Fernando Cánovas García; Julián Castillo Sánchez; Francisco Javier López-Román
Journal:  Nutrients       Date:  2020-05-19       Impact factor: 5.717

Review 4.  Comparing cancer and cardiovascular disease trends in 20 middle- or high-income countries 2000-19: A pointer to national trajectories towards achieving Sustainable Development goal target 3.4.

Authors:  Freddie Bray; Mathieu Laversanne; Bochen Cao; Cherian Varghese; Bente Mikkelsen; Elisabete Weiderpass; Isabelle Soerjomataram
Journal:  Cancer Treat Rev       Date:  2021-09-09       Impact factor: 12.111

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.